Albireo to Participate in the Needham 20th Annual Virtual Healthcare Conference Apr 6, 2021 08:30AM
Albireo Pharma (ALBO) PT Raised to $68 at Needham & Company Sep 8, 2020 12:23PM
Pre-Open Movers 09/08: (ALBO) (NKLA) (SPRO) Higher; (CRBP) (ACMR) (TSLA) Lower (more...) Sep 8, 2020 09:26AM
Albireo to Present at 19th Annual Needham Healthcare Conference Apr 7, 2020 08:30AM
Albireo Reports First Quarter 2019 Financial Results May 9, 2019 07:30AM


Apr 1, 2019 07:30AM Albireo to Present at Investor Conferences in April
May 17, 2018 07:30AM Albireo Provides First Quarter 2018 Business Update
Mar 21, 2018 08:00AM Albireo to Present at 17th Annual Needham & Company Healthcare Conference
Feb 2, 2018 07:25AM Albireo Pharma (ALBO) PT Raised to $50 at Needham & Company; Elobixibat Approval and Royalty Deal
Jan 29, 2018 04:01PM Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 25, 2018 08:46AM Albireo Pharma (ALBO) Prices 1.97M Common Stock Offering at $33/Share
Jan 25, 2018 08:45AM Albireo Prices $65.0 Million Public Offering of Common Stock
Jan 24, 2018 04:02PM Albireo Pharma (ALBO) to Offer Common Stock
Jan 24, 2018 04:01PM Albireo Announces Proposed Public Offering of Common Stock
Jul 18, 2017 06:56AM Needham & Company Starts Albireo Pharma (ALBO) at Buy
May 30, 2017 04:01PM Albireo Announces Closing of $51.9 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
May 24, 2017 08:40AM Albireo Pharma (ALBO) Prices 2.2M Common Stock Offering at $20.50/Share
May 24, 2017 08:39AM Albireo Prices $45.1 Million Public Offering of Common Stock
May 23, 2017 04:02PM Albireo Pharma (ALBO) Commences Offering of Common Stock
May 23, 2017 04:01PM Albireo Announces Proposed Public Offering of Common Stock
Mar 28, 2017 08:00AM Albireo to Present at Upcoming Investor Conferences